Company: BOLT
Filing Date: 2025-04-15
Form Type: DEF 14A
Source: 0000950170-25-054294
Chunk: 1

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-04-15
Form: DEF 14A
Chunk 1
---
31, 2025; 3. Approval of an amendment to our certificate of incorporation to effect a reverse stock split of our issued and outstanding common stock; and 4. To conduct any other business properly brought before the 2025 Annual Meeting of Stockholders. These items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. The record date for the 2025 Annual Meeting of Stockholders is April 15, 2025. Only stockholders of record at the close of business on that date are entitled to receive notice of, and to vote at, the 2025 Annual Meeting of Stockholders or any adjournment thereof. A list of stockholders of record at the close of business on the April 15, 2025 record date will be available during the Annual Meeting at www.proxydocs.com/BOLT and electronically for the 10 days ending the day prior to the Annual Meeting to registered stockholders for any legally valid purpose related to the Annual Meeting. For access to the stockholder list, please contact us at investors@boltbio.com. The Board of Directors recommends that you vote as follows on the matters to be presented to stockholders at the 2025 Annual Meeting of Stockholders: 1. FOR the election of each of our Class I director nominees named in Proposal No. 1 of the proxy statement; 2. FOR the ratification of the selection by the audit committee of the Board of Directors of PricewaterhouseCoopers LLP, as the independent registered public accounting firm, as described in Proposal No. 2 of the proxy statement; and 3. FOR the approval of an amendment to our certificate of incorporation to effect a reverse stock split of our issued and outstanding common stock, as described in Proposal No. 3 of the proxy statement. Your vote is very important. Whether or not you attend the 2025 Annual Meeting of Stockholders (by logging into www.proxydocs.com/BOLT ), it is important that your shares be represented. We encourage you to read the accompanying Proxy Statement and our Annual Report on Form 10-K for the year ended December 31, 2024, and submit your proxy on the internet, by phone or by mail in accordance with the instructions in these materials. Please review the instructions on the enclosed proxy card or the information forwarded by your bank, broker or other holder of record regarding each of these voting options. If you receive more than one set of proxy materials because your shares are registered in different names or